2021
DOI: 10.30659/nurscope.5.1.45-51
|View full text |Cite
|
Sign up to set email alerts
|

Cervical Cancer Self Management Education (CSME) meningkatkan kualitas hidup pasien dengan kanker serviks

Abstract: Kanker serviks merupakan salahsatu penyakit kronis dengan berbagai gejala penyerta selama sepanjang hidup pada penderita. Pasien dengan kanker serviks dapat melakukan manajemen diri terhadap gejala. Beberapa memiliki kemampuan untuk beradaptasi terhadap gejala yang muncul, namun ada juga yang mengungkapkan ketidaksiapan dalam mengelola gejala. Informasi kesehatan sangat penting untuk pasien, berupa mempromosikan rasa kontrol, menurunkan tekanan emosional, mendukung manajemen diri yang efektif, dan menghilangka… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…According to cost, performin g VIA every 10 years was the cheapest strategy while HPV DNA every 3 years was the most expensive. Insights from developed nations indicate that employing both Pap smear and HPV DNA screening methods is effective and economically efficient, decreasing cervical cancer incidence and mortality by more than half (Shi et al, 2011;Wuriningsih & Distinarista, 2019). The relative order of testing technologies in reducing cervical cancer incidence and mortality is VIA (least effective); VIA/VILI; careHPV@1.0 pg/ml, and careHPV@0.5 pg/ml (most effective) (Shi et al, 2011).…”
Section: ) Effectivenessmentioning
confidence: 99%
“…According to cost, performin g VIA every 10 years was the cheapest strategy while HPV DNA every 3 years was the most expensive. Insights from developed nations indicate that employing both Pap smear and HPV DNA screening methods is effective and economically efficient, decreasing cervical cancer incidence and mortality by more than half (Shi et al, 2011;Wuriningsih & Distinarista, 2019). The relative order of testing technologies in reducing cervical cancer incidence and mortality is VIA (least effective); VIA/VILI; careHPV@1.0 pg/ml, and careHPV@0.5 pg/ml (most effective) (Shi et al, 2011).…”
Section: ) Effectivenessmentioning
confidence: 99%